首页 › 基金 › AMI ASSET MANAGEMENT CORP › MDGL
AMI ASSET MANAGEMENT CORP 对 MDGL 的持仓历史
MADRIGAL PHARMACEUTICALS INC · 医疗保健
AMI ASSET MANAGEMENT CORP 在 Q2 2026 的 13F 申报中披露持有 MDGL(MADRIGAL PHARMACEUTICALS INC)2,135 股,市值约 US$1.1M,约占其申报组合的 0.07%,在其申报持仓中市值排名第 43 位。 AMI ASSET MANAGEMENT CORP 最近 11 个申报季度中有 11 个季度披露了 MDGL 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
AMI ASSET MANAGEMENT CORP 对 MDGL 的持仓演变
AMI ASSET MANAGEMENT CORP 于 Q4 2023 首次披露 MDGL 持仓:4,773 股(约 US$1.1M)。 该持仓在 Q1 2024 达到峰值 9,618 股,市值约 US$2.6M。 在 11 次申报中,AMI ASSET MANAGEMENT CORP 2 次增持、7 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 2,135 股、市值约 US$1.1M,环比减持 -478 股。。 持仓曾出现大幅变动:Q1 2024 增持约 102% (随后一个季度股价上涨 5%)、Q2 2024 减持约 43% (随后一个季度股价下跌 24%)、Q2 2025 减持约 37% (随后一个季度股价上涨 52%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 4.77K | $1.10M | 新进 |
| Q1 2024 | 9.62K | $2.57M | 增持 |
| Q2 2024 | 5.49K | $1.54M | 减持 |
| Q3 2024 | 5.01K | $1.06M | 减持 |
| Q4 2024 | 4.98K | $1.54M | 减持 |
| Q1 2025 | 5.50K | $1.82M | 增持 |
| Q2 2025 | 3.44K | $1.04M | 减持 |
| Q3 2025 | 3.43K | $1.57M | 持有 |
| Q4 2025 | 2.75K | $1.60M | 减持 |
| Q1 2026 | 2.61K | $1.37M | 减持 |
| Q2 2026 | 2.13K | $1.15M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MDGL 与 13F 数据
MDGL(MADRIGAL PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 MDGL,申报仓位最大的包括:BAKER BROS. ADVISORS LP (US$1.15B), RTW INVESTMENTS, LP (US$1.07B), 骏利亨德森集团 (US$1.05B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MDGL 的基金
- BAKER BROS. ADVISORS LP 2.14M 股 · $1.15B · Q2 2026
- RTW INVESTMENTS, LP 1.99M 股 · $1.07B · Q2 2026
- 骏利亨德森集团 2.02M 股 · $1.05B · Q1 2026
- Jupiter Topco LLC 1.94M 股 · $1.04B · Q2 2026
- Avoro Capital Advisors LLC 1.83M 股 · $984.41M · Q2 2026
- 保尔森基金 1.34M 股 · $719.52M · Q2 2026
- PAULSON & CO. INC. 1.34M 股 · $719.52M · Q2 2026
- ARMISTICE CAPITAL, LLC 288.00K 股 · $154.64M · Q2 2026
- Rock Springs Capital Management LP 175.00K 股 · $93.97M · Q2 2026
- Erste Asset Management GmbH 110.21K 股 · $58.11M · Q2 2026
更多关于 AMI ASSET MANAGEMENT CORP
常见问题
How long has AMI ASSET MANAGEMENT CORP held MDGL?
AMI ASSET MANAGEMENT CORP has disclosed MDGL holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is AMI ASSET MANAGEMENT CORP's current position in MDGL?
As of Q2 2026, AMI ASSET MANAGEMENT CORP holds 2.13K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $1.15M, representing 0.07% of its reported portfolio and ranking #43.
Has AMI ASSET MANAGEMENT CORP been buying or selling MDGL?
In the latest 13F filing (Q2 2026), AMI ASSET MANAGEMENT CORP reduced its position in MDGL. The position peaked in Q1 2024 at 9.62K shares.
Which other funds hold MDGL?
Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, 骏利亨德森集团, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.